Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population studyAntonietta Romano, A. Albertí, Paolo Angeli et al.|Journal of Hepatology|2018Cited by 166
A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis CGiovanna Fattovich, A. Tagger, M. Capanni et al.|Journal of Hepatology|2003Cited by 27
SAT-262-Long-term liver function outcome and related risk factors in HCV cirrhotic patients treated with direct-acting antiviral therapy: Results from the Navigatore platform in Veneto-ItalyFrancesco Paolo Russo, A. Albertí, Martina Gambato et al.|Journal of Hepatology|2019Cited by 0
Final report of a consensus interferon (CIFN) plus ribavirin (RBV) study for chronic hepatitis C (CHC)I. Zagni, Giovanna Fattovich, E. Minóla et al.|Unknown|2003Cited by 0
Impact of HBV infection in HCV/HBV coinfected patients treated with DAAs IN Northern ItalyPaolo Fabris, S. Fagiuoli, Franco Noventa et al.|Digestive and Liver Disease|2020Cited by 0